Related Experiment Video

Updated: Jul 7, 2026

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

Fungal vaccines: real progress from real challenges

Antonio Cassone1

  • 1Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, Rome, Italy. cassone@iss.it

The Lancet. Infectious Diseases
|January 29, 2008
PubMed

Insights

Fungal infections lack vaccines, unlike viral or bacterial diseases. Recent advances in understanding host-fungus interactions and new technologies are driving progress in developing effective fungal vaccines and immunotherapies.

Area of Science:

  • Mycology
  • Immunology
  • Vaccinology

Background:

  • Fungal infections represent a significant global health burden.
  • Unlike viral and bacterial diseases, no vaccines currently exist for fungal pathogens.
  • Conventional treatments are often insufficient, especially in immunocompromised individuals.

Purpose of the Study:

  • To review the current state and future prospects of fungal vaccine development.
  • To highlight the challenges and advancements in creating immunological tools against fungal infections.

Main Methods:

  • Review of recent literature on fungal pathogenesis and host-immune responses.
  • Analysis of progress in genetic engineering, proteomics, and genome sequencing for vaccine design.
  • Evaluation of preclinical and passive vaccination studies.

Main Results:

  • Vaccine candidates are emerging that induce fungicidal antibodies.
  • Protective immunity has been demonstrated in animal models with risk factors like CD4+ T-cell deficiency and neutropenia.
  • Passive vaccination strategies using antibodies show promising efficacy.

Conclusions:

  • Significant progress is being made in fungal vaccine research.
  • Advances in host-fungus relations and technology are paving the way for new immunological interventions.
  • There is growing optimism for the future availability of safe and effective fungal vaccines and therapies for vulnerable populations.

More Related Videos

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

A Contemporary Warming/Restraining Device for Efficient Tail Vein Injections in a Murine Fungal Sepsis Model06:02

A Contemporary Warming/Restraining Device for Efficient Tail Vein Injections in a Murine Fungal Sepsis Model

Published on: November 6, 2020

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccinations01:51

Vaccinations

Overview
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...